Before you sell to, join or invest in ADIAL PHARMACEUTICALS, INC.
MentionFox check on ADIAL PHARMACEUTICALS, INC.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/adial-pharmaceuticals-inc-form-d-25000002
Check ADIAL PHARMACEUTICALS, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about ADIAL PHARMACEUTICALS, INC.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
ADIAL PHARMACEUTICALS, INC. filed a Form D with the Securities and Exchange Commission on 2025-05-14.
ADIAL PHARMACEUTICALS, INC. filed a Form D notice of an exempt securities offering with the SEC on May 14, 2025. The filing reports $4.82M sold. Its industry group is Pharmaceuticals. It names Cary Claiborne (Chief Executive Officer), Vinay Shah (Chief Financial Officer), James Anderson (Director) (SEC Form D, May 14, 2025).
Is this your company?
Sell to companies like ADIAL PHARMACEUTICALS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ADIAL PHARMACEUTICALS, INC.
Free to see. No signup.
More on the people and the money behind ADIAL PHARMACEUTICALS, INC., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when ADIAL PHARMACEUTICALS, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ADIAL PHARMACEUTICALS, INC. raises, hires or launches. No email unless you switch it on.
Watch ADIAL PHARMACEUTICALS, INC. →Get the full cited report on ADIAL PHARMACEUTICALS, INC.
What the filing shows about ADIAL PHARMACEUTICALS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ADIAL PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives ADIAL PHARMACEUTICALS, INC.'s address as 4870 Sadler Road, Suite 300, Glen Allen, VA 23060.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on ADIAL PHARMACEUTICALS, INC. See pricing
ADIAL PHARMACEUTICALS, INC. is a registered filer with the SEC (CIK 1513525) and has filed since 2023-03-06. 6 filings are on record, the latest on 2025-12-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ADIAL PHARMACEUTICALS, INC.'s Form D of 2025-05-14 names Cary Claiborne, Vinay Shah, James Anderson and 4 more as its officers, directors or promoters.
Its new offerings report $13.50M sold across 6 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer, Director.
Cary Claiborne is named as Chief Executive Officer on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
On the filing as: Executive Officer.
Vinay Shah is named as Chief Financial Officer on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
James Anderson is named as Director on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
Robertson Gilliland is named as Director on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
James Newman, Jr. is named as Director on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
Kevin Schuyler, CFA is named as Director on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
On the filing as: Executive Officer, Director.
Tony Goodman is named as Chief Operating Officer on the Form D that ADIAL PHARMACEUTICALS, INC. filed with the SEC on 14 May 2025, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2025-05-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about ADIAL PHARMACEUTICALS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ADIAL PHARMACEUTICALS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ADIAL PHARMACEUTICALS, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ADIAL PHARMACEUTICALS, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind ADIAL PHARMACEUTICALS, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for ADIAL PHARMACEUTICALS, INC.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/adial-pharmaceuticals-inc-form-d-25000002